Why the study?
Do aldosterone antagonists improve ejection fraction and functional capacity in patients with systolic heart failure?
Do aldosterone antagonists improve ejection fraction and functional capacity in patients with systolic heart failure?
Answers are grounded in this paper and cite their sources.
Aldosterone antagonists significantly improve ejection fraction and functional class in systolic heart failure patients, independent of baseline functional capacity.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Lang et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: